<SEC-DOCUMENT>0001193125-25-005313.txt : 20250113
<SEC-HEADER>0001193125-25-005313.hdr.sgml : 20250113
<ACCEPTANCE-DATETIME>20250113161012
ACCESSION NUMBER:		0001193125-25-005313
CONFORMED SUBMISSION TYPE:	DEFR14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20250113
DATE AS OF CHANGE:		20250113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FRANKLIN COVEY CO
		CENTRAL INDEX KEY:			0000886206
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT SERVICES [8741]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				870401551
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		DEFR14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11107
		FILM NUMBER:		25526478

	BUSINESS ADDRESS:	
		STREET 1:		2200 W PARKWAY BLVD
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84119-2331
		BUSINESS PHONE:		8018175030

	MAIL ADDRESS:	
		STREET 1:		2200 W PARKWAY BLVD
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRANKLIN QUEST CO
		DATE OF NAME CHANGE:	19940218
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFR14A
<SEQUENCE>1
<FILENAME>d881957ddefr14a.htm
<DESCRIPTION>DEFR14A
<TEXT>
<HTML><HEAD>
<TITLE>DEFR14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;2) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&#8194;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&#8194;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to &#167; <FONT STYLE="white-space:nowrap">240.14a-12</FONT>
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g881957g0113223639480.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FRANKLIN COVEY CO. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FRANKLIN COVEY CO. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 2 TO THE PROXY STATEMENT DATED DECEMBER&nbsp;20, 2024 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE ANNUAL MEETING OF SHAREHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD ON JANUARY&nbsp;24, 2025 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following information amends disclosures in the definitive proxy statement of Franklin Covey Co. (the Company) filed with the U.S.&nbsp;Securities and Exchange Commission on December&nbsp;20, 2024, and amended on January 13, 2025 (as amended, the
Proxy Statement), and furnished to shareholders of the Company in connection with the solicitation of proxies by the Board of Directors of the Company for the 2025 Annual Meeting of Shareholders of the Company, to be held on Friday, January&nbsp;24,
2025 at 8:30 a.m., in the Fontainbleau Room at The Grand America Hotel, 555 South Main Street, Salt Lake City, Utah 84111, and any adjournment or postponement thereof (the Annual Meeting). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is filing this Amendment No.&nbsp;2 to the Proxy Statement (this Amendment) to include certain historical information relating to the securities
authorized for issuance under the Company&#146;s equity compensation plans. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Securities Authorized for Issuance Under Equity Compensation Plans
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The text below is hereby added immediately prior to the heading &#147;<B>Market Value</B>&#148; on page 59 of the Proxy Statement: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Securities Authorized for Issuance Under Equity Compensation Plans at August&nbsp;31, 2024 </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="18%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">[a]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">[b]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">[c]</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Plan Category</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;securities&nbsp;to&nbsp;be<br>issued upon exercise of<br>outstanding options,<br>warrants, and rights</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="white-space:nowrap">Weighted-average</FONT><br>exercise price of<br>outstanding&nbsp;options,<br>warrants, and rights</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;securities&nbsp;remaining<BR>available for future issuance<br>under equity compensation<br>plans (excluding securities<br>reflected in
column [a])</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">(in&nbsp;thousands)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">(in&nbsp;thousands)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">905</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(1)(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">996</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)(4)</SUP>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Excludes 23,136 shares of unvested stock awards that are subject to forfeiture. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount includes 905,231 performance share awards that may be awarded under the terms of various long-term
incentive plans, including stock-based compensation plans associated with the acquisition of Strive in fiscal 2021. The number of shares eventually awarded to participants through some of our long-term incentive plans is variable and based upon the
achievement of specified financial goals. For performance-based compensation awards where the number of shares may fluctuate within a range based on the achievement of the specified goal, this amount includes the maximum number of shares that may be
awarded to participants. The actual number of shares issued to participants therefore, may be less than the amount disclosed. At August&nbsp;31, 2024 we did not have any unexercised stock options outstanding. For further information on our
stock-based compensation plans, refer to the notes to our financial statements as presented in Item 8 of this report. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount is comprised of the remaining shares authorized under our 2022 Omnibus Incentive Plan and 2017 Employee
Stock Purchase Plan. The number of performance-based plan shares expected to be awarded at August&nbsp;31, 2024 may change in future periods based upon the achievement of specified goals and revisions to estimates. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At August&nbsp;31, 2024, we had approximately 689,000 shares authorized for purchase by participants in our
Employee Stock Purchase Plan. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Except as described above, this Amendment does not modify, amend, supplement, revise, replace, update or
otherwise affect any of the other disclosures in the Proxy Statement, which continue to speak as of December&nbsp;20, 2024, as amended by the Amendment No.&nbsp;1 filed on January 13, 2025. This Amendment does not provide all of the information that
is important to your voting decisions at the Annual Meeting and should be read in conjunction with the Proxy Statement, which contains other important information. From and after the date of this Amendment, any references to the &#147;Proxy
Statement&#148; are to the Proxy Statement as amended hereby. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>If you have already voted, you do not need to vote again unless you would like to
change or revoke your prior vote on any proposal. If you would like to change or revoke your prior vote on any proposal, please refer to the paragraph under the heading &#147;May I revoke my vote prior to the Annual Meeting?&#148; on page&nbsp;3 in
the Proxy Statement for instructions on how to do so.</I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g881957g0113223639480.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g881957g0113223639480.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  U 2,# 2(  A$! Q$!_\0
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MQU\CEKX6C55Y:/N8_A2[>2P>SF5EEMFQAA@[3T_K70UE:5J]KJT]P;6-ML>
M92,;CZ5JUE7O[1MJWD:4$E323N?+.JV-KJ?QZN;&^4-:W&K^7,I. 5(&>:]D
M_P"%4_#_ /Y\8?\ P(/^->(^*--FUGXSZGIEM*(I[K4S%'(?X20.:Z[_ (47
MXI_Z#\/_ 'V])^IH=MJ_B_PW\)(K/1+339WM[A'N4$+@@9;!Y/O2)\:-'N_&
M%GH-A:RW"W$ZPFZWA4!/4@=P.:\I^*^D7/AV'PMI=W,)[BUTQU>0$X8^83WK
MU_0O /AK3O $'VB"*&1[$23W[<2(63+,#VQDTK*UQZF=K?QTT2PU"2STVRN=
M2:-BK21<*<=<>OUK4\&_%O1?%NHKIIBEL;YP?+BE.0Y'4 ^OM7F^A>*_!7@N
MZNXO#>DWNLW$VU1+*@( '9?8FN;DU*YU#XO:3J<NE?V3+/>VSBV"[<#<%S^.
M#1RH5SVS5_BUHVA^,)?#U];SQM$RB2Y)&Q05W9_6N;F_:$TI+LK#H]U);[L"
M0N 6'KBN(\>V$6J_'EM.G)\FZO+6%\?W65 ?TKU/XJ>%=&3X::E+!I\$$EC&
MLL#1H 5(8<?B,BBR'J.\;:_8>)O@GK&JZ;(7MYK<=1@J0ZY!'J*R?V?W6/P3
MJCNP5%OV+,3@ >6G-<3X2E=O@)XUB))1)U*CTR(\_P JXZS\87VF^"+KPW9$
MQ)>7+37$H/+)M50@].AS3MI85]3WVS^,.F:IXG_L/2=-N[Z5I3&DT9&Q@.K^
MRCUKSGQ3_P G)VG_ %_V7_H*5Z+\'O#.BZ9X2M]5L)$NKR]0&>XQRI[QCTQT
MKSOQ3_R<G:?]?]E_Z"E)6OH'0Z7XAZGX(MOB!'#K>B75UJ>V#$\<F%P3\O'M
M77>-?B=IW@C5K;3[VSN)Y)X?.#1D8 W%?Z5Y!\8O^2OQ?[EK_P"A5;_:%S_P
MF.FXZ_V=Q_W\:BU[#N=?JWQ]T:SOI(+#3KB]A0[?/W! Q]JZ_0?B)HWB'PM?
M:Y:ET6PC9[F!_OQX4M^1 X-0)X&T-?AZ=+33H"#8_?*C<7V?>SUSGFO"/AU'
M=7>B>-K.!V!DT1G*CN5;_#(_&BR:#4E\+Z3??%KX@3SZI<2"+!N+EE/W(\X6
M-?3KC\#7MLWP@\%RV+6PTE8R5P)48[Q[Y]:\X_9YNX$UO6K5F FFMHI(QZA6
M;/\ Z$*^@J)-I@CQ3P+\,_%/A#QTU[#=0?V4LC12;GYGA/0[?4<'ZBNX\:?$
MK1/!16"Z9[B^==RVT74#U8]JZQ+RUDF:%+B(RHVUD#C(/IBOFOP391^-_C-=
M3:R!.@EGN7C<\-L;:J_09''M26NK#8[BR_:!TJ2Z2.]TBZMH6ZR!@V/?'<5T
MOB?XKZ1X;MM-NQ;37UGJ$3203P$;3CJOUY%'Q.\)Z1?^ =3E%G!#/96[3P2Q
MH%*E!G''8@8_&O$-"M)]?^%7B"T 9VT6XBU"WXSM5@PD4?@-WX4TDPU/J'2]
M1@U?2;34;8Y@NH5F0^S#-<5HOQ9TK7O%<FA6EG<9C:7?<L0(U2/.7/MQ^M<?
MX'\;_P!G_ S5G:3_ $K2M]O",\_O/]7^K'_OFN!T>SGT?X4:YKZ[EDU&XCTR
M*3N(\[I#^) 7\*%$+GK&K_'31[747M-*T^ZU/82&DBX4X].,D>]:_@[XL:-X
MMO#IXBELM1P2D$Q_UA'8'U]J\J^'7BZ+PKH;"+PE<ZA<32,SW:)D$= H]ABL
MKQ7J-]K'BVU\0Z/X:O=,GAV.ZK$?FD5LAN!Z<&CE0KGM7A?XL:7XF\3?V"MC
M<VEWB0?OB,;DZK]>#^5;OC/QC8^"M%34KZ.257F6%(X_O,2"?T ->'>/H7\%
M?%NP\1VZ%+>Z>._ ' STE7\>3_P*M+XX:G)KWBC0O#NGMYI\M9%"]Y)B G_C
MHS^-'+J.YZ?HWCV37=)@U*RT"]:VGW;&+#G#%3^H-%=%H>E0Z%H5CI5N!Y5I
M"L0]\#D_B>:*@9YA\1-*_L_Q$+M%Q#>KO^CCAOZ'\:SM(\4ZKI) @N6:,?\
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M3=3#_EI/S^2]*Z-0 H   '  HHKBJ59U7S3=V;QA&"M%6%HS116909HS110
M9HS110 9HS110 9HS110 9HS110 9HS110 9HS110 9HS110 9HS110 9HS1
<10 9HS110 9HS110 9HHHH **** #-%%% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
